Moffitt Cancer Center study suggests elevation in inflammation marker IL-6 linked to higher levels of fatigue in prostate cancer patients receiving androgen deprivation therapy (ADT).
from Medindia Health News https://ift.tt/3bbXJOp
LATEST HEALTH NEWS
Reviewed by MZ Digital Marketing Agency
on
January 06, 2021
Rating: 5
No comments
Thanks for comment via will connect you within 24 hours.
No comments
Thanks for comment via will connect you within 24 hours.